Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Microbiol., 23 October 2025

Sec. Infectious Agents and Disease

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1721908

This article is part of the Research TopicPathogenic microorganisms and biosafetyView all 22 articles

Correction: Ire1 inhibitors attenuate Candida albicans pathogenicity and demonstrate potential for application in antifungal therapy

This article is a correction to:

  1. Ire1 inhibitors attenuate Candida albicans pathogenicity and demonstrate potential for application in antifungal therapy

    1. Read original article
Hua Wang&#x;Hua Wang†Mengyan Li&#x;Mengyan Li†Qiuyue Wang&#x;Qiuyue Wang†Huihai ZhaoHuihai ZhaoMengyu JiangMengyu JiangQi CuiQi CuiDaxin LeiDaxin LeiKeran Jia Keran Jia*Fukun Wang Fukun Wang*
  • Department of Clinical Laboratory, Bethune International Peace Hospital, Shijiazhuang, China

A Correction on
Ire1 inhibitors attenuate Candida albicans pathogenicity and demonstrate potential for application in antifungal therapy

by Wang, H., Li, M., Wang, Q., Zhao, H., Jiang, M., Cui, Q., Lei, D., Jia, K., and Wang, F. (2025). Front. Microbiol. 16:1648467. doi: 10.3389/fmicb.2025.1648467

Affiliation “Department of Clinical Laboratory, Bethune International Peace Hospital, Shijiazhuang, China” was omitted for author Mengyan Li

This affiliation has now been added for author Mengyan Li.

Author Mengyan Li was erroneously assigned to affiliation Department of Clinical Laboratory, The First Hospital of Hebei Medical University, Shijiazhuang, China.

This affiliation has now been removed for author Mengyan Li.

The original version of this article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Candida albicans, endoplasmic reticulum, Ire1, Ire1 inhibitor, 4μ8c, pathogenicity

Citation: Wang H, Li M, Wang Q, Zhao H, Jiang M, Cui Q, Lei D, Jia K and Wang F (2025) Correction: Ire1 inhibitors attenuate Candida albicans pathogenicity and demonstrate potential for application in antifungal therapy. Front. Microbiol. 16:1721908. doi: 10.3389/fmicb.2025.1721908

Received: 10 October 2025; Accepted: 13 October 2025;
Published: 23 October 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Wang, Li, Wang, Zhao, Jiang, Cui, Lei, Jia and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Keran Jia, a2VyYW5qaWFAc2luYS5jb20=; Fukun Wang, d2FuZ2ZrOEBzaW5hLmNvbQ==

†These authors share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.